This site is intended for healthcare professionals only
LoginRegister
USFDA nod to JnJ Tremfya for Crohns diseaseJudge certifies JnJ shareholder class action over talc disclosures
US judge rules in favor of Teva over patent spat with Corcept TherapeuticsUS judge rules in favor of Teva over patent spat with Corcept Therapeutics
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkRoche enters into agreement to acquire LumiraDx Point of Care technology combining multiple...
AstraZeneca to Invest USD 15 Billion in China by 2030Submit safety, efficacy data of Indian Patients: CDSCO Panel Tells AstraZeneca on additional...
Bayer Pharma gets CDSCO Panel nod to study Asundexian 50mg tabletsBayer Pharma gets CDSCO Panel nod to study Asundexian 50mg tablets
CDSCO Expert Panel Backs Akums Faropenem Dispersible Tablets, Grants CT, BE WaiversRevise BE study protocol: CDSCO Panel tells Akum Pharma on FDC of Chlorthalidone, Cilnidipine,...
US FDA turns down full approval of Amgen lung cancer drug LumakrasUS FDA turns down full approval of Amgen lung cancer drug Lumakras
Venus Remedies secures marketing nod from Israel, Colombia for two oncology drugsVenus Remedies secures marketing nod from Israel, Colombia for two oncology drugs
Exit Exam now mandatory for D.Pharm students, PCI directs state councils not to register new passouts until exam is clearedExit Exam now mandatory for D.Pharm students, PCI directs state councils not to register new...
Delhi Vigilance Dept sends suspected spurious drugs matter to Health Ministry, urges CBI probeDelhi Vigilance Dept sends suspected spurious drugs matter to Health Ministry, urges CBI probe
Cell, gene therapy to rule pharma sector in 2024: ReportCell, gene therapy to rule pharma sector in 2024: Report
Biological E Gets CDSCO Panel Nod to study safety of XBB 1.5-RBD Subunit Covid-19 Vaccine in 5-80 years oldBiological E Gets CDSCO Panel Nod to study safety of XBB 1.5-RBD Subunit Covid-19 Vaccine in 5-80...
X